V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216539 | 20168647 | 1.72 | 0 | Palliative (P) | 2019-04-30 | 2019-07-13 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100949925 |
| 20216541 | 20168648 | 1.77 | 96 | Neo-adjuvant (N) | 2019-10-25 | 2019-11-02 | Capecitabine 35days + RT | N | Y | CAPECITABINE + RT | 100750855 |
| 20216542 | 20168649 | 1.46 | null | Palliative (P) | 2018-08-22 | 2018-08-23 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100867680 |
| 20216547 | 20168650 | 1.81 | 71.3 | Palliative (P) | 2019-02-10 | 2019-02-10 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100543523 |
| 20216557 | 20168651 | 1.66 | 76 | Palliative (P) | 2020-05-11 | 2020-05-28 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100582991 |
| 20216562 | 20168652 | 1.75 | 100.6 | Neo-adjuvant (N) | 2020-05-24 | 2020-06-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 100008372 |
| 20216566 | 20168653 | 1.57 | 56 | Palliative (P) | 2022-03-13 | 2022-03-14 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101644618 |
| 20216578 | 20168654 | 1.54 | 48 | null | 2019-03-10 | 2019-09-16 | Sorafenib | 02 | null | SORAFENIB | 101509275 |
| 20216581 | 20168655 | 1.68 | 86 | null | 2017-03-20 | 2017-03-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100401974 |
| 20216588 | 20168656 | 1.83 | 85.3 | Palliative (P) | 2021-12-21 | 2021-12-21 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101753902 |
| 20216589 | 20168657 | 1.81 | 104 | Palliative (P) | 2018-05-20 | 2018-06-10 | GO2 TRIAL | 2 | N | TRIAL | 101552512 |
| 20216598 | 20168658 | 1.72 | 85.05 | Palliative (P) | 2017-08-08 | 2017-08-08 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100329184 |
| 20216600 | 20168659 | 1.73 | 85.4 | null | null | 2021-02-28 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100437111 |
| 20216607 | 20168660 | 1.74 | 104.2 | Palliative (P) | null | 2020-03-25 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100611291 |
| 20216617 | 20168661 | 1.9 | 57.5 | Palliative (P) | 2021-01-13 | 2021-06-04 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100315977 |
| 20216618 | 20168662 | 1.74 | 67.1 | null | 2019-09-28 | 2019-09-29 | CETUXIMAB + IRINOTECAN + MDG | 01 | null | CETUXIMAB + IRINOTECAN + MDG | 100292925 |
| 20216621 | 20168663 | 1.7 | 83.1 | null | 2019-07-17 | 2019-08-07 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101826216 |
| 20216624 | 20168664 | 1.72 | 67.1 | Neo-adjuvant (N) | 2019-11-21 | 2019-12-11 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101680703 |
| 20216640 | 20168665 | 1.79 | 103 | Curative (C) | 2017-08-25 | 2017-09-22 | Sorafenib | 02 | Y | SORAFENIB | 101216275 |
| 20216641 | 20168666 | 1.69 | 58.8 | Palliative (P) | 2016-09-18 | 2018-02-06 | EOX | 2 | null | EOX | 101537855 |
| 20216655 | 20168667 | 1.7 | 57.6 | null | 2020-05-24 | 2020-05-31 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100303594 |
| 20216662 | 20168668 | null | 46.2 | null | 2018-03-18 | 2018-03-28 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101184567 |
| 20216669 | 20168669 | 1.56 | 64.8 | Palliative (P) | 2020-02-18 | 2020-04-01 | Sorafenib | 02 | N | SORAFENIB | 101816080 |
| 20216687 | 20168670 | 1.92 | 69.9 | Palliative (P) | 2018-07-07 | 2018-08-16 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100742205 |
| 20216690 | 20168671 | 1.7 | 75 | Palliative (P) | 2017-08-28 | 2017-08-30 | Oxaliplatin + Raltitrexed | 01 | N | OXALIPLATIN + RALTITREXED | 101094116 |
| 20216704 | 20168672 | 1.85 | 108 | null | 2021-05-11 | 2021-06-06 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | null | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100428088 |
| 20216722 | 20168673 | 1.72 | 60.55 | Palliative (P) | 2018-02-02 | 2018-04-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100987004 |
| 20216724 | 20168674 | 1.74 | 82 | Palliative (P) | 2017-03-13 | 2017-04-09 | Sorafenib | 02 | N | SORAFENIB | 100546967 |
| 20216726 | 20168675 | 1.67 | 93 | Neo-adjuvant (N) | 2021-04-21 | 2021-07-24 | Sorafenib | 02 | N | SORAFENIB | 101614751 |
| 20216731 | 20168676 | 1.7 | 109 | null | 2020-07-16 | 2020-07-25 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100670296 |
| 20216736 | 20168677 | 1.56 | 81.2 | Palliative (P) | 2018-06-13 | 2019-05-20 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101472208 |
| 20216742 | 20168678 | 1.64 | 93.6 | Palliative (P) | null | 2021-05-26 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101063161 |
| 20216771 | 20168679 | 1.62 | 50 | Neo-adjuvant (N) | 2018-02-19 | 2018-02-20 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101213204 |
| 20216786 | 20168680 | 1.46 | 71.1 | Palliative (P) | 2017-08-08 | 2017-08-13 | Cetuximab + FOLFIRI cycle1 | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101392092 |
| 20216821 | 20168681 | 1.48 | 119.6 | Palliative (P) | 2017-01-25 | 2017-02-07 | Sorafenib | 02 | N | SORAFENIB | 101668537 |
| 20216827 | 20168682 | 1.45 | 78.1 | 03 | 2019-05-11 | 2019-05-31 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100944095 |
| 20216830 | 20168683 | 1.63 | 97.6 | Palliative (P) | 2017-06-14 | 2018-06-08 | GO2 TRIAL | N | N | TRIAL | 100142642 |
| 20216852 | 20168684 | 1.78 | 65.4 | Palliative (P) | 2016-09-29 | 2016-09-29 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100990357 |
| 20216854 | 20168685 | 1.66 | 90 | Palliative (P) | 2020-03-20 | 2020-04-12 | Trial Unspecified | 02 | N | TRIAL | 100202583 |
| 20216865 | 20168686 | 1.8 | 86.7 | Palliative (P) | 2016-07-02 | 2017-12-12 | EOX | 02 | N | EOX | 101333133 |
| 20216875 | 20168687 | 1.61 | 69.5 | Palliative (P) | 2019-06-04 | 2019-06-09 | Sorafenib | 02 | N | SORAFENIB | 100144530 |
| 20216887 | 20168688 | 1.6 | 80.5 | Palliative (P) | 2017-07-22 | 2017-07-22 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101647133 |
| 20216905 | 20168689 | 1.71 | 64 | Palliative (P) | 2018-09-18 | 2018-11-01 | Trial Unspecified | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101603517 |
| 20216933 | 20168690 | 1.7 | 75.3 | Palliative (P) | 2019-06-25 | 2019-10-21 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101866015 |
| 20216937 | 20168691 | 1.83 | 47.3 | null | 2019-04-28 | 2019-05-13 | Trial Unspecified | 02 | N | TRIAL | 100202544 |
| 20216941 | 20168692 | 1.6 | 71.4 | Palliative (P) | 2016-09-27 | 2016-10-27 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100150606 |
| 20216947 | 20168693 | 1.61 | 80.5 | null | 2019-10-11 | 2019-10-19 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101111928 |
| 20216965 | 20168694 | 1.74 | 51.6 | Palliative (P) | 2018-07-06 | 2018-07-18 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101527100 |
| 20216987 | 20168695 | 1.81 | 70.6 | null | null | 2018-04-14 | Sorafenib | 02 | null | SORAFENIB | 100702430 |
| 20217065 | 20168696 | 1.71 | 80.1 | null | 2019-03-30 | 2019-05-02 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101733217 |